CVE-2018-14787CWE-269

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges…

published August 22, 2018

CVSS
—
EPSS
0%
Percentile
32.0
In the wild
Unconfirmed
What it is

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

The record
Technical detail
CVSS
Not scored
CVSS v4.0
Not supplied
EPSS
0.00390 · 32.0th percentile
Weakness
CWE-269 · Improper Privilege Management
Published
2018-08-22T18:00Z
EPSS history
Timeline
  • 22 AUG 18:00Z
    In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges…
    cvelistv5